An antibody-based leukocyte-capture microarray for the diagnosis of systemic lupus erythematosus.
The diagnosis of Systemic Lupus Erythematosus (SLE) is challenging due to its heterogeneous clinical presentation and the lack of robust biomarkers to distinguish it from other autoimmune diseases. Further, currently used laboratory tests do not readily distinguish active and inactive disease. Sever...
Guardado en:
Autores principales: | Ming-Wei Lin, Joshua W K Ho, Leonard C Harrison, Cristobal G dos Remedios, Stephen Adelstein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/798173b379cf434fbe86dc1d2009945c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies
por: Jacob M van Laar, et al.
Publicado: (2021) -
Moulage: "Lupus Erythematosus"
por: Beatrix Patzak
Publicado: (2011) -
Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy
por: Helena Idborg, et al.
Publicado: (2021) -
Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
por: Vojislav Jovanović, et al.
Publicado: (2013) -
Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.
por: Barbara M Colombo, et al.
Publicado: (2012)